SI — Shoulder Innovations Inc
NYSE · Health Care · Health Care
- Latest Close
- $13.88
- 30-Day Move
- -8.4%
- Market Cap
- $297M
- Shares Outstanding
- 20,650,000
- P/B Ratio
- 2.09
- ROE
- -8.7%
Shoulder Innovations Inc
A read-only Alphactor snapshot forShoulder Innovations Inc. It uses the same research structure as the app, but with delayed data and shallow depth so search visitors can evaluate the stock before signing up.
Snapshot as of2026-04-21
Topline snapshot
Latest Close
$13.88
30-Day Move
-8.4%
Market Cap
$297M
Shares Outstanding
20,650,000
P/B Ratio
2.09
ROE
-8.7%
$13.88
-8.4%last 90 delayed daily bars
90D High
$15.76
90D Low
$12.00
Avg Volume
76,255
Gross margin is running at 76.6%, which gives a quick read on operating quality before you open the full model.
Net margin is -9.9%, useful for comparing SI against peers in Health Care.
SI is down 8.4% over the last 30 trading days shown on this page.
Latest operating income is $-9M, which helps anchor the headline ratios with an actual earnings figure.
Composite Fair Value
$12.03
Rule of 40
-26.5%
Dark Pool Short %
37.5%
Latest Close
$13.88
30-Day Move
-8.4%
Market Cap
$297M
Shares Outstanding
20,650,000
P/B Ratio
2.09
ROE
-8.7%
ROA
-7.2%
Gross Margin
76.6%
Operating Margin
-52.5%
Net Margin
-9.9%
Debt / Equity
0.11
Current Ratio
11.07
Latest Revenue
$14M
Revenue
$14M
Gross Profit
$11M
Operating Income
$-9M
Net Income
$-8M
Gross Margin
7660.0%
Net Margin
-986.0%
Current Ratio
11.07
Debt / Equity
0.11
Fair Value
$12.03
Upside / Downside
-13.3%
Signal
Overvalued
Implied Growth
--
EV/Rev
$12.03
Growth Assumption
50.0%
Discount Rate
10.5%
Terminal Growth
2.0%
Base FCF
--
Valuation spread
After signup
The full valuation workspace goes deeper
Adjust DCF growth, discount, and terminal assumptions instead of relying on one static snapshot.
Open the deeper balance-sheet and cash-flow views to inspect debt, liquidity, and cash generation line by line.
Compare multiple valuation models against peers and save your own thesis instead of re-reading a fixed public state.
Negative FCF — company is cash-flow negative. Reverse DCF requires positive cash flows.
Altman Z
6.09
Safe
Piotroski
5
Moderate (4-6)
Cash Conversion
0.71x
Rule of 40
-26.5%
Concerning
Annual performance mix
| Period | Revenue | Operating Income | Net Income | Free Cash Flow |
|---|---|---|---|---|
| 2023-12-31 | $19M | $-11M | $-13M | $-16M |
| 2024-12-31 | $32M | $-15M | $-16M | $-18M |
| 2025-12-31 | $47M | $-26M | $-40M | $-36M |
After signup
The app opens the full statement deep dive
Extend the history well beyond this public snapshot to inspect longer cycles and regime changes.
Move from summary lines into detailed balance-sheet and cash-flow rows for working capital, debt, and capex analysis.
Cross-link statement changes with alerts, watchlists, and saved research workflows after signup.
After signup
The full sentiment workspace adds context
Go past the public headlines into fuller article history, source cross-checks, and deeper narrative tracking.
Tie news into alerts, watchlists, and conviction changes instead of browsing one static batch of stories.
Buy Value
$12M
Sell Value
$0
Buys
17
Sells
0
Buy Value
$12M
Sell Value
$0
Buy/Sell Ratio
17.00x
After signup
The full app goes deeper on insider behavior
Inspect longer insider history, recurring buyers and sellers, and the broader transaction context beyond this snapshot.
Continue into deeper institutional and alternative-data views once you sign up.
| Date | Name | Type | Shares | Price |
|---|---|---|---|---|
| 2026-04-20 | Ahearn Matthew Fraser | M | 14,243 | $0.00 |
| 2026-04-20 | Ahearn Matthew Fraser | M | 7,421 | $0.00 |
| 2026-04-20 | Ahearn Matthew Fraser | M | 14,243 | $2.86 |
| 2026-04-20 | Ahearn Matthew Fraser | M | 7,421 | $2.48 |
| 2026-03-13 | Ball Robert Joseph | Buy | 2,200 | $15.18 |
| 2026-03-13 | Buchholz Richard | Buy | 1,000 | $14.84 |
| 2026-03-13 | Points Jeffrey S. | M | 13,264 | $0.00 |
| 2026-03-13 | Points Jeffrey S. | Buy | 2,000 | $15.00 |
| ETF | Shares | Weight | As Of |
|---|---|---|---|
| Fidelity Select PORT.s-Select Medical Technology and Devices PORT. | 947,763 | 0.05% | 2026-02-28 |
| Fidelity Select Portfolios-Select Health Care Portfolio | 545,286 | 0.03% | 2026-02-28 |
| Fidelity Puritan Trust-Fidelity Balanced Fund | 505,572 | 0.02% | 2026-02-28 |
| Fidelity Securities Fund-Fidelity Small Cap Growth Fund | 116,000 | 0.01% | 2026-01-31 |
| iShares Trust-iShares Russell 2000 ETF | 102,669 | 0.01% | 2026-02-28 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 93,101 | 0.00% | 2025-12-31 |
| Variable Insurance Products Fund IV-VIP Health Care Portfolio | 89,551 | 0.00% | 2026-02-28 |
| Variable Insurance Products Fund III-Balanced Portfolio | 68,600 | 0.00% | 2026-02-28 |
After signup
The deeper ownership view shows who is leaning in
Open richer institutional and holder diffs to see position changes across filings instead of one static snapshot.
Use those ownership shifts alongside conviction and alerts in the full app workflow.
FMR LLC (Fidelity)
Filed 2026-02-17
$55M
+0.0%
Vanguard Group
Filed 2026-01-29
$3M
+50.7%
Marshall Wace
Filed 2025-11-13
$2M
--
Geode Capital Management
Filed 2026-02-09
$2M
+17.3%
Citadel Advisors
Filed 2025-11-14
$627,500
--
Northern Trust
Filed 2026-02-17
$510,410
-6.4%
Renaissance Technologies
Filed 2026-02-12
$175,890
--
Charles Schwab
Filed 2026-02-13
$168,440
+0.0%
For informational and educational purposes only. Not financial advice. Learn more
Related reading
Research and strategy guides from the alphactor blog.
Healthcare Investing: Pharma, Biotech, and the FDA Calendar
A framework for navigating healthcare stocks across pharma, biotech, and medical devices, with emphasis on regulatory catalysts and pipeline valuation.
Accruals Quality: How to Spot Earnings That Aren't Real
Accruals measure the gap between reported earnings and actual cash. Widening accruals is one of the most reliable red flags in financial analysis — Sloan's…
Altman Z-Score: A Bankruptcy Predictor That Still Works
Edward Altman's 1968 discriminant model predicts bankruptcy within two years about 72% of the time at its distress threshold.